Vestcor Inc Moderna, Inc. Transaction History

Vestcor Inc

$3.17 Billion
Q3 2024

A detailed history of Vestcor Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Vestcor Inc holds 5,714 shares of MRNA stock, worth $232,902. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,714

Previous 5,714 -0.0%

Holding current value

$232,902

Previous $679,000 43.74%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $101,590 - $137,373	-1,190 Reduced 17.24%	5,714 $609,000
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $5,213 - $7,832	-75 Reduced 1.07%	6,904 $687,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $81,852 - $107,491	-849 Reduced 10.85%	6,979 $721,000
Q2 2023 Aug 15, 2023	SELL	$118.5 - $160.53 $3,081 - $4,173	-26 Reduced 0.33%	7,828 $951,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $179,885 - $261,248	-1,326 Reduced 14.44%	7,854 $1.21 Million
Q4 2022 Feb 15, 2023	SELL	$118.38 - $210.04 $270,853 - $480,571	-2,288 Reduced 19.95%	9,180 $1.65 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $236 - $388	-2 Reduced 0.02%	11,468 $1.36 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $705,122 - $1.06 Million	6,020 Added 110.46%	11,470 $1.64 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.31 Million - $2.44 Million	-10,390 Reduced 65.59%	5,450 $939,000
Q4 2021 Feb 15, 2022	SELL	$225.82 - $368.51 $410,089 - $669,214	-1,816 Reduced 10.29%	15,840 $4.02 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $669,916 - $1.46 Million	3,019 Added 20.63%	17,656 $6.8 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $1.9 Million - $3.44 Million	14,637 New	14,637 $3.44 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account